Pain vs. Cognitive Health: The Risks of Glucosamine Supplementation
Many Americans seek relief from pain through popular supplements like glucosamine, but emerging research raises concerns about their cognitive effects, especially for older adults.
Key Findings:
- Dementia Risk: About 42% of Americans over 55 face a risk of dementia, with a similar percentage of older adults suffering from arthritis.
- Glucosamine Use: Over 40 million Americans take glucosamine to alleviate joint pain. However, a recent study published in Nature Metabolism found that those with Alzheimer’s taking glucosamine had a 25% higher risk of death within five years compared to non-users.
- Cognitive Decline: Users with mild cognitive impairment were more likely to progress to full-blown Alzheimer’s. Mouse studies suggested that glucosamine worsened memory in those with Alzheimer’s-like symptoms.
- Protein Accumulation: Alzheimer’s is marked by toxic protein clumps, particularly tau, which disrupt cognitive function. Additionally, excess sugar buildup on brain cells can worsen memory issues and lead to cell death—a phenomenon known as hyperglycosylation.
Contrasting Views:
While some studies suggested glucosamine may lower dementia risk in cognitively healthy adults, the link between glucosamine and cognitive decline remains ambiguous. Dr. Jacob Teitelbaum, a pain specialist, argues that chronic arthritis pain might be the true culprit behind increased dementia risk, not glucosamine itself.
Conclusion:
Research on glucosamine’s effects continues, with prospects of new compounds aimed at preventing sugar accumulation on brain cells. Meanwhile, dietary choices, particularly high sugar and saturated fats, are also linked to inflammation and increased dementia risk. It’s crucial for individuals, especially those with arthritis or cognitive impairments, to weigh the risks and benefits of glucosamine and seek comprehensive approaches to pain management and cognitive health.
